Newark, NJ — Choose New Jersey, the state’s leading nonprofit economic development organization, today announced that biopharmaceutical and biotechnology leader Meteoric Biopharmaceuticals USA, LLC, has expanded its global operations to New Jersey. Meteoric Biopharmaceuticals is headquartered in India, with an office in Vietnam. Its newest facility will operate out of Morris Plains, New Jersey.

“I am so proud to welcome Meteoric Biopharmaceuticals to New Jersey,” said Wesley Mathews, President & CEO of Choose New Jersey. “This expansion adds to the state’s impressive roster of industry leaders in the life sciences sector. As New Jersey continues its storied history of developing lifesaving pharmaceuticals, we are thrilled to continue developing a strong global network of the world’s smartest minds who bring their talents to our great state.”

Meteoric Biopharmaceuticals is a first-generation, research driven, integrated, and diversified global biopharmaceuticals leader. Aligning with the New Jersey philosophy of “Innovations through Discovery,” the company services 500 customers across 50 industries in more than 90 countries. Today, Meteoric is a one-stop solution for biological requirements across enzymes, probiotics, nutraceuticals, finished formulations, and animal health care. Its mission prioritizes quality assurance, making sure processes from product customization and concept formulation, all the way to contract manufacturing take place all under one roof. Meteoric owns 10 patents and over 50 trademarks and is a leader in quality and compliance across regulated markets.

“Having a physical presence in New Jersey is essential for Meteoric to reach the next level in biopharmaceutical manufacturing,” said Gaurav Kaushik, MD & CEO of Meteoric Biopharmaceuticals. “In addition to its ideal proximity to our target markets, New Jersey has one of the most advanced pharmaceutical ecosystems in the United States. We are thrilled to plant roots here, while continuing to prioritize quality assurance for clients old and new.”

“This expansion brings together two powerhouses in the pharmaceutical industry,” said Tarun Gupta, Representative to the New Jersey India Center. “Meteoric Biopharmaceuticals is already a global leader – expanding to New Jersey and gaining access to the state’s exceptional talent pool and pharmaceutical ecosystem will further solidify the company’s position around the world.”

The Morris Plains facility will primarily act as a distribution warehouse where Meteoric will store an inventory of enzymes, probiotics, and nutraceuticals. Situated less than 30 miles from Port Newark and Newark Liberty International Airport, it is the perfect location to ship goods throughout the U.S. market, and export goods across the globe. The facility will create nearly a dozen new jobs and plans to add more positions in 2023. Meteoric plans to undertake additional Research and Development projects in the United States with New Jersey at the center of its North American operations.

Meteoric’s expansion into New Jersey enriches the state’s thriving global life sciences hub. The company now joins an industry powerhouse, where 14 of the top 20 global pharmaceutical companies have headquarters. New Jersey’s diverse talent pool includes the highest concentration of scientists and engineers per square mile in the country.

About Meteoric Biopharmaceuticals Pvt. Ltd.
Meteoric Biopharmaceuticals Pvt. Ltd. excels in manufacturing and marketing of Enzymes & Enzymatic Preparations, Probiotics & Nutraceuticals for a wide range of industries. Incorporated in 2006, Meteoric Biopharmaceuticals Pvt. Ltd. is a renowned name in the global biopharmaceutical landscape. Since its inception in 2006, the company has worked ceaselessly to research, develop, manufacture, and market specialized biological, pharmaceutical, and biotechnology products. Living up to its promise of high-quality products and unparalleled technical support, Meteoric now exports to over 70 countries worldwide, including the U.S., Japan, Brazil, the UK, Germany, South Korea, and Canada. Visit www.meteoricbiopharma.com to learn more.

About Choose New Jersey, Inc.
Choose New Jersey is a privately funded 501 (c)(3) economic development organization with a mission to stimulate job creation and attract capital investment to New Jersey. Choose New Jersey markets New Jersey both domestically and internationally as the best place to grow a business in the United States. Knowledgeable, experienced staff, supported by a network of State agencies and private partners, provide free, confidential assistance to guide companies in establishing operations in New Jersey. By harnessing the power of business, labor, academic, and government leaders, Choose New Jersey enables growth across all sectors of the State’s economy, aspiring to build a stronger and more prosperous New Jersey for all. To learn more, visit choosenj.com.

About Choose New Jersey India Center
The New Jersey India Center was founded in 2019 during Governor Murphy’s historic business attraction trip to India with the New Jersey delegation. The office showcases New Jersey’s vested interest in the subcontinent and helps Indian companies looking to expand or break into the North American market. Our services include detailed market assessment services, customized business proposal responses, site selection assistance, government resources information, and introductions to public-private partnerships. Let us help you discover your second home in New Jersey. To learn more, visit choosenj.com/njic.